Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1/2 1Phase 1 1

Status

Unknown 88Completed 52Recruiting 25Not yet recruiting 20Terminated 9Active not recruiting 6Withdrawn 4Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Stomach Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 61Radiotherapy 55Gemcitabine 51Paclitaxel 49Cyclophosphamide 48Cisplatin 48Carboplatin 45Dexamethasone 37Bevacizumab 37Nivolumab 35Fluorouracil 34Docetaxel 34Oxaliplatin 33durvalumab 32Rituximab 28Magnetic Resonance Spectroscopy 28Leucovorin 28Drug Therapy 25Pemetrexed 24Doxorubicin 24Capecitabine 24atezolizumab 22Radiation 20Cytarabine 20Radiosurgery 19Prednisone 19Etoposide 19Irinotecan 17Bortezomib 17Cetuximab 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Withdrawn × S 1 (combination) × Clear all
NCT04863430 2025-02-21

Apatinib with Oxaliplatin and S-1 Treatment for Advanced Hepatoid Adenocarcinoma of the Stomach

Peking University

Phase 2 Withdrawn
Gastrointestinal

Stomach Neoplasms

NCT02716688 2023-09-22

S-1 and Radiotherapy for Elderly Esophageal Cancer Patients

Zhejiang Provincial People's Hospital

Phase 2 Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT03843853 2022-07-25

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Withdrawn
Gastrointestinal

Colorectal Neoplasms

NCT02129322 2021-02-15

Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1

Zhejiang University

Phase 2 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡